JP2009539914A5 - - Google Patents

Download PDF

Info

Publication number
JP2009539914A5
JP2009539914A5 JP2009514716A JP2009514716A JP2009539914A5 JP 2009539914 A5 JP2009539914 A5 JP 2009539914A5 JP 2009514716 A JP2009514716 A JP 2009514716A JP 2009514716 A JP2009514716 A JP 2009514716A JP 2009539914 A5 JP2009539914 A5 JP 2009539914A5
Authority
JP
Japan
Prior art keywords
alkyl
group
hydrogen
preferably selected
molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009514716A
Other languages
English (en)
Japanese (ja)
Other versions
JP5475442B2 (ja
JP2009539914A (ja
Filing date
Publication date
Priority claimed from EP06090109A external-priority patent/EP1867648A1/en
Application filed filed Critical
Priority claimed from PCT/EP2007/005432 external-priority patent/WO2007144204A1/en
Publication of JP2009539914A publication Critical patent/JP2009539914A/ja
Publication of JP2009539914A5 publication Critical patent/JP2009539914A5/ja
Application granted granted Critical
Publication of JP5475442B2 publication Critical patent/JP5475442B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2009514716A 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類 Expired - Fee Related JP5475442B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP06090109.7 2006-06-13
EP06090109A EP1867648A1 (en) 2006-06-13 2006-06-13 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them.
EP07090020.4 2007-02-15
EP07090020 2007-02-15
PCT/EP2007/005432 WO2007144204A1 (en) 2006-06-13 2007-06-12 Substituted aminopyrazolopyridines and salts thereof, their preparations and pharmaceutical compositions comprising them

Publications (3)

Publication Number Publication Date
JP2009539914A JP2009539914A (ja) 2009-11-19
JP2009539914A5 true JP2009539914A5 (https=) 2010-07-29
JP5475442B2 JP5475442B2 (ja) 2014-04-16

Family

ID=38445661

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2009514716A Expired - Fee Related JP5475442B2 (ja) 2006-06-13 2007-06-12 置換されたアミノピラゾロピリン類及びそれらの塩類、それらの調製及びそれらを含んで成る医薬組成物類

Country Status (21)

Country Link
US (1) US7846928B2 (https=)
EP (1) EP2061790B1 (https=)
JP (1) JP5475442B2 (https=)
KR (1) KR20090018212A (https=)
AR (1) AR061346A1 (https=)
AU (1) AU2007260216A1 (https=)
BR (1) BRPI0711961A2 (https=)
CA (1) CA2654789C (https=)
CL (1) CL2007001711A1 (https=)
CR (1) CR10505A (https=)
EA (1) EA200802407A1 (https=)
EC (1) ECSP088963A (https=)
ES (1) ES2515117T3 (https=)
GT (1) GT200800285A (https=)
IL (1) IL195813A0 (https=)
MX (1) MX2008015955A (https=)
NO (1) NO20090171L (https=)
PE (1) PE20080205A1 (https=)
TW (1) TW200815438A (https=)
UY (1) UY30409A1 (https=)
WO (1) WO2007144204A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
CA2704266A1 (en) * 2007-11-02 2009-06-11 Vertex Pharmaceuticals Incorporated [1h- pyrazolo [3, 4-b] pyridine-4-yl] -phenyle or -pyridin-2-yle derivatives as protein kinase c-theta
EP2300427A1 (en) * 2008-05-05 2011-03-30 Amgen Inc. Urea compounds as gamma secretase modulators
EP2307456B1 (en) 2008-06-27 2014-10-15 Amgen Inc. Ang-2 inhibition to treat multiple sclerosis
US8653098B2 (en) 2008-11-20 2014-02-18 Genentech, Inc. Pyrazolopyridine PI3K inhibitor compounds and methods of use
EP2464647B1 (en) 2009-08-11 2016-09-21 Bristol-Myers Squibb Company Azaindazoles as btk kinase modulators and use thereof
EP2516437B1 (en) 2009-12-21 2014-01-29 Novartis AG Disubstituted heteroaryl-fused pyridines
ES2625727T3 (es) * 2012-03-26 2017-07-20 Arroyo Biosciences L.L.C. Nuevos antagonistas de receptores de esfingosina-1-fosfato
US20150164910A1 (en) * 2012-06-15 2015-06-18 The Regents Of The University Of Califonia Antiviral compounds and methods of use
WO2017053604A1 (en) 2015-09-23 2017-03-30 The Regents Of The University Of California Potent antiviral pyrazolopyridine compounds
JOP20190024A1 (ar) 2016-08-26 2019-02-19 Gilead Sciences Inc مركبات بيروليزين بها استبدال واستخداماتها
BR112020003725A2 (pt) 2017-10-06 2020-11-03 Forma Therapeutics, Inc. inibição da peptidase 30 específica de ubiquitina
PL3759109T3 (pl) 2018-02-26 2024-03-04 Gilead Sciences, Inc. Podstawione związki pirolizyny jako inhibitory replikacji hbv
JP7449242B2 (ja) 2018-05-17 2024-03-13 フォーマ セラピューティクス,インコーポレイテッド ユビキチン特異的ペプチダーゼ30(usp30)阻害剤として有用な縮合二環化合物
LT3860989T (lt) 2018-10-05 2023-06-12 Forma Therapeutics, Inc. Sulieti pirolinai, kurie veikia kaip ubikvitinui specifinės proteazės 30 (ups30) inhibitoriai
TW202136238A (zh) * 2020-01-06 2021-10-01 大陸商廣東東陽光藥業有限公司 RORγt抑制劑及其製備方法和用途

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670364B2 (en) * 2001-01-31 2003-12-30 Telik, Inc. Antagonists of MCP-1 function and methods of use thereof
JP4810427B2 (ja) * 2003-05-22 2011-11-09 アボット・ラボラトリーズ インダゾール、ベンズイソオキサゾールおよびベンズイソチアゾールキナーゼ阻害剤
US20070293511A1 (en) * 2003-12-22 2007-12-20 Sb Pharmco Puerto Rico Inc. And Neurocrine Biosciences, Inc., A Corporation Crf Receptor Antagonists and Methods
FR2876691B1 (fr) * 2004-10-18 2006-12-29 Sanofi Aventis Sa Derives de pyridine, leur preparation, leur application en therapeutique
US7812166B2 (en) * 2004-10-29 2010-10-12 Abbott Laboratories Kinase inhibitors
PE20061119A1 (es) * 2005-01-19 2006-11-27 Aventis Pharma Sa PIRAZOLO PIRIDINAS SUSTITUIDAS COMO INHIBIDORES DE CINASAS FAK, KDR Y Tie
EP1683796A1 (en) * 2005-01-24 2006-07-26 Schering Aktiengesellschaft Pyrazolopyridines, their preparation and their medical use
RS50821B (sr) * 2005-06-27 2010-08-31 Sanofi-Aventis Derivati pirazolopiridina kao inhibitori beta-adrenergičnog receptora kinaze 1

Similar Documents

Publication Publication Date Title
JP2009539914A5 (https=)
JP2009539912A5 (https=)
JP2010523596A5 (https=)
JP2012520247A5 (https=)
JP2006096962A5 (https=)
JP2011121940A5 (ja) 発光素子
JP2009062537A5 (https=)
RU2011101140A (ru) Пирроло[2,3-b]пиридиновые производные в качестве ингибиторов протеинкиназ
JP2013147496A5 (ja) 有機金属錯体
JP2013040159A5 (ja) 有機金属錯体
DE602005023185D1 (de) Prodrugs mit neuen biospaltbaren verbindern
DE602005010804D1 (de) Herstellung von Metallverbindungen der 12. und 13. Gruppe, die niedrige Mengen an Sauerstoff-enthaltenden Verunreinigungen aufweisen
JP2014029971A5 (ja) 有機化合物
MX2007012090A (es) Derivados sustituidos de pirazoliloxifenilo como herbicidas.
JP2010504908A5 (https=)
JP2009541403A5 (https=)
JP2013509487A5 (https=)
JP2010520851A5 (https=)
DE602004029363D1 (de) N-alkynyl-2-(substituierte aryloxy)alkylthioamide derivate als fungizide
JP2005515295A5 (https=)
JP2007523941A5 (https=)
JP2005289914A5 (https=)
JP2004535412A5 (https=)
WO2005074598A3 (en) Nitroxyl progenitor compounds and methods of use
JP2020504434A5 (https=)